Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment

Authors: Adela Wu, Russell Maxwell, Yuanxuan Xia, Pina M. Cardarelli, Miho Oyasu, Zineb Belcaid, Eileen Kim, Alice Hung, Andrew S. Luksik, Tomás Garzón-Muvdi, Christopher M. Jackson, Dimitrios Mathios, Debebe Theodros, John Cogswell, Henry Brem, Drew M. Pardoll, Michael Lim - Journal of Neuro-Oncology 2019 cited by 147